Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-12-06 00:00:00 ET · period of report 2023-12-04 · accession 0001968202-23-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-06 | 2023-12-05 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $817.44 | -6,536 | 59.4K | -10% | -$5.34M |
| D | 2023-12-06 | 2023-12-04 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $270.43 | +20.0K | 79.4K | +34% | +$5.41M |
| D | 2023-12-06 | 2023-12-04 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $813.58 | -13.5K | 66.0K | -17% | -$10.95M |
| D | 2023-12-06 | 2023-12-04 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-05 | S | D | 136 | $810.38 | 65,821 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-05 | S | D | 103 | $811.37 | 65,718 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-05 | S | D | 372 | $812.57 | 65,346 | D | — | — | (F2) Represents volume-weighted average price of sales of 372 shares of Company stock on December 5, 2023 at prices ranging from $812.26 to $812.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price. |
| 4 | Common | Common Stock | 2023-12-05 | S | D | 167 | $813.66 | 65,179 | D | — | — | (F3) Represents volume-weighted average price of sales of 167 shares of Company stock on December 5, 2023 at prices ranging from $813.00 to $813.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price. |
| 5 | Common | Common Stock | 2023-12-05 | S | D | 58 | $814.06 | 65,121 | D | — | — | |
| 6 | Common | Common Stock | 2023-12-05 | S | D | 155 | $815.97 | 64,966 | D | — | — | (F4) Represents volume-weighted average price of sales of 155 shares of Company stock on December 5, 2023 at prices ranging from $815.90 to $815.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price. |
| 7 | Common | Common Stock | 2023-12-05 | S | D | 829 | $816.46 | 64,137 | D | — | — | (F5) Represents volume-weighted average price of sales of 829 shares of Company stock on December 5, 2023 at prices ranging from $816.01 to $816.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price. |
| 8 | Common | Common Stock | 2023-12-05 | S | D | 1,881 | $817.36 | 62,256 | D | — | — | (F6) Represents volume-weighted average price of sales of 1,881 shares of Company stock on December 5, 2023 at prices ranging from $817.04 to $817.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price. |
| 9 | Common | Common Stock | 2023-12-05 | S | D | 1,333 | $818.59 | 60,923 | D | — | — | (F7) Represents volume-weighted average price of sales of 1,333 shares of Company stock on December 5, 2023 at prices ranging from $818.07 to $818.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price. |
| 10 | Common | Common Stock | 2023-12-05 | S | D | 973 | $819.57 | 59,950 | D | — | — | (F8) Represents volume-weighted average price of sales of 973 shares of Company stock on December 5, 2023 at prices ranging from $819.03 to $819.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price. |
| 11 | Common | Common Stock | 2023-12-05 | S | D | 345 | $820.54 | 59,605 | D | — | — | (F9) Represents volume-weighted average price of sales of 345 shares of Company stock on December 5, 2023 at prices ranging from $820.27 to $820.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price. |
| 12 | Common | Common Stock | 2023-12-05 | S | D | 184 | $821.46 | 59,421 | D | — | — | (F10) Represents volume-weighted average price of sales of 184 shares of Company stock on December 5, 2023 at prices ranging from $821.39 to $821.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price. |
| 13 | Common | Common Stock | 2023-12-04 | M | A | 20,000 | $270.43 | 79,421 | D | — | — | |
| 14 | Common | Common Stock | 2023-12-04 | F | D | 13,464 | $813.58 | 65,957 | D | — | — | |
| 15 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-12-04 | M | D | 20,000 | $0.00 | 0 | D | $270.43 · — to 2023-12-13 | 20,000 Common Stock | (F11) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |